Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

NCT06108414 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

4374

Enrollment

OTHER_GOV

Sponsor class

Conditions

Atrial Fibrillation
Anticoagulant Adverse Reaction
Stroke
Major Adverse Cardiac Events

Interventions

DRUG: low-dose rivaroxaban
DRUG: Standard-dose rivaroxaban

Sponsor

China National Center for Cardiovascular Diseases